Vera Therapeutics, Inc.
VERA
$39.96
-$1.21-2.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.46% | -4.92% | -48.05% | -19.04% | 6.88% |
| Total Depreciation and Amortization | 4.65% | 8.40% | 40.00% | 54.55% | 129.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.80% | 16.28% | 23.96% | 35.09% | 27.36% |
| Change in Net Operating Assets | 19.30% | -35.09% | 241.79% | -1,196.43% | -112.42% |
| Cash from Operations | -13.06% | -12.97% | -0.72% | -38.85% | -6.23% |
| Capital Expenditure | 23.31% | 36.06% | -11.23% | 71.01% | -171.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.55% | 143.09% | 85.45% | 107.02% | -672.53% |
| Cash from Investing | 15.63% | 144.40% | 86.36% | 106.92% | -677.77% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 38,066.50% | 71.77% | -69.73% | -99.56% | 46,084.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | 35,819.95% | -96.07% | 1,223.22% | -99.53% | 44,007.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,332.18% | 244.95% | 84.11% | -157.43% | 2,911.98% |